UNC-45A is overexpressed in breast and ovarian cancer as compared to their normal counterpart [24,25,26] and in ovarian cancer patients that are resistant to the MT-stabilizing drug paclitaxel [6]. Here, UNC45A is linked to ovarian cancer.